214 related articles for article (PubMed ID: 2772395)
1. [Activity of the coagulation and fibrinolysis in non-insulin-dependent diabetes mellitus. In vivo study].
Conti M; Marongiu F; Mameli G; Mamusa AM; Cambuli AB; Cossu E; Sorano GG; Biondi G; Cirillo R; Balestrieri A
Recenti Prog Med; 1989 Jun; 80(6):297-9. PubMed ID: 2772395
[TBL] [Abstract][Full Text] [Related]
2. In vivo measurements of fibrin formation and fibrinolysis in operable breast cancer.
McCulloch P; Douglas J; Lowe GD; Murray G; George WD
Thromb Haemost; 1989 Apr; 61(2):318-21. PubMed ID: 2749603
[TBL] [Abstract][Full Text] [Related]
3. Subclinical activation of fibrinolysis in atherosclerotic disease detected by B beta 15-42 assay.
Marongiu F; Mamusa AM; Mameli G; Conti M; Sorano GG; Biondi G; Farci P; Balestrieri A
Ric Clin Lab; 1989; 19(2):157-63. PubMed ID: 2528202
[TBL] [Abstract][Full Text] [Related]
4. [Coagulation-fibrinolysis abnormalities in acute stage of subarachnoid hemorrhage (Part 1)--With special reference to the relation between cerebral vasospasm and fibrinopeptides A and B beta].
Touho H; Hino A; Suzuki K; Kubo T; Hirakawa K
No To Shinkei; 1984 Oct; 36(10):1009-14. PubMed ID: 6518124
[TBL] [Abstract][Full Text] [Related]
5. "Falsely increased" B beta 15-42 levels in diabetes.
Marongiu F; Conti M; Mameli G; Sorano GG; Cirillo R; Balestrieri A
Diabetes Care; 1990 Nov; 13(11):1129-30. PubMed ID: 2082993
[No Abstract] [Full Text] [Related]
6. Abnormalities of blood coagulation and fibrinolysis in psoriasis.
Marongiu F; Sorano GG; Bibbò C; Pistis MP; Conti M; Mulas P; Balestrieri A; Biggio P
Dermatology; 1994; 189(1):32-7. PubMed ID: 7516205
[TBL] [Abstract][Full Text] [Related]
7. Fibrinopeptide A and B beta 15-42 in liver cirrhosis.
Marongiu F; Mameli G; Acca MR; Mulas G; Medda A; Tronci MB; Mamusa AM; Balestrieri A
Haemostasis; 1988; 18(2):126-8. PubMed ID: 2457543
[TBL] [Abstract][Full Text] [Related]
8. Blood coagulation and fibrinolysis in obese NIDDM patients.
Avellone G; Di Garbo V; Cordova R; Rotolo G; Abruzzese G; Raneli G; De Simone R; Bompiani GD
Diabetes Res; 1994; 25(2):85-92. PubMed ID: 7648783
[TBL] [Abstract][Full Text] [Related]
9. Plasma concentrations of fibrinopeptide A and fibrinopeptide B beta 15-42 in glomerulonephritis and the nephrotic syndrome.
Tomura S; Oono Y; Kuriyama R; Takeuchi J
Arch Intern Med; 1985 Jun; 145(6):1033-5. PubMed ID: 4004427
[TBL] [Abstract][Full Text] [Related]
10. [Effects of acid-base balance and Apgar score on fibrinopeptide A and fibrinopeptide B beta 15-42 in umbilical cord blood].
Ogura H; Adachi H; Takeda T; Nakagomi H; Kanno S; Yokoyama M; Kinoshita T
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jan; 39(1):128-34. PubMed ID: 3102647
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
12. [Blood coagulation and fibrinolysis in anesthesia and operations, with special reference to FPA, FPB beta 15-42].
Gando S; Tedo I; Hanaoka Y; Makise N; Tsujinaga H; Kubota M
Masui; 1988 Apr; 37(4):451-6. PubMed ID: 3398226
[No Abstract] [Full Text] [Related]
13. [Plasma fibrinopeptide A, fibrinopeptide B beta 15-42 and 4 other coagulation factors levels in patients with diabetic retinopathy].
Yamamoto M; Denno S; Sunakawa M
Nippon Ganka Gakkai Zasshi; 1992 Nov; 96(11):1443-8. PubMed ID: 1476075
[TBL] [Abstract][Full Text] [Related]
14. [Significance of fibrinopeptide A as an indicator for coagulative analysis in thrombotic diseases].
Murakoshi T
Hokkaido Igaku Zasshi; 1982 May; 57(3):351-63. PubMed ID: 6957368
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the coagulation and fibrinolysis system in 54 patients with type 2 diabetes mellitus: correlations with lipid metabolism and blood glucose control].
Moccia F; Colla G; Castelli F; Greco GM
Clin Ter; 1996; 147(1-2):37-46. PubMed ID: 8767954
[TBL] [Abstract][Full Text] [Related]
16. [Coagulation and fibrinolysis in chronic subdural hematoma. Measurement of fibrinopeptides].
Harada K; Orita T; Abiko S; Aoki H
Neurol Med Chir (Tokyo); 1989 Feb; 29(2):113-6. PubMed ID: 2475799
[TBL] [Abstract][Full Text] [Related]
17. Is the imbalance between thrombin and plasmin activity in diabetes related to the behaviour of antiplasmin activity?
Marongiu F; Conti M; Mameli G; Sorano GG; Cossu E; Cirillo R; Balestrieri A
Thromb Res; 1990 Apr; 58(2):91-9. PubMed ID: 1693451
[TBL] [Abstract][Full Text] [Related]
18. Thrombin and plasmin activity in diabetes mellitus and their association with glycaemic control.
Small M; Lowe GD; MacCuish AC; Forbes CD
Q J Med; 1987 Dec; 65(248):1025-31. PubMed ID: 2971234
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of reactivity to airborne and food allergens in cutaneous vasculitis by variations in fibrinopeptide A and other blood coagulation, fibrinolysis and complement parameters.
Theorell H; Blombäck M; Kockum C
Thromb Haemost; 1976 Dec; 36(3):593-604. PubMed ID: 1037153
[TBL] [Abstract][Full Text] [Related]
20. Activation of blood coagulation and fibrinolysis in Graves' disease.
Marongiu F; Conti M; Murtas ML; Mameli G; Sorano GG; Martino E
Horm Metab Res; 1991 Dec; 23(12):609-11. PubMed ID: 1778596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
